Amphastar Asks 9th Circ. To Revive Sanofi Patent FCA Suit
Generic-drug maker Amphastar urged the Ninth Circuit to revive a False Claims Act suit alleging Sanofi overcharged Medicare for an anti-clotting drug that was patented under false pretenses, saying Thursday it...To view the full article, register now.
Already a subscriber? Click here to view full article